210 related articles for article (PubMed ID: 26167477)
1. Functional and Structural Abnormalities in Deferoxamine Retinopathy: A Review of the Literature.
Di Nicola M; Barteselli G; Dell'Arti L; Ratiglia R; Viola F
Biomed Res Int; 2015; 2015():249617. PubMed ID: 26167477
[TBL] [Abstract][Full Text] [Related]
2. Multimodal imaging in deferoxamine retinopathy.
Viola F; Barteselli G; DellʼArti L; Vezzola D; Mapelli C; Villani E; Ratiglia R
Retina; 2014 Jul; 34(7):1428-38. PubMed ID: 24378427
[TBL] [Abstract][Full Text] [Related]
3. The expanded clinical spectrum of deferoxamine retinopathy.
Haimovici R; D'Amico DJ; Gragoudas ES; Sokol S;
Ophthalmology; 2002 Jan; 109(1):164-71. PubMed ID: 11772599
[TBL] [Abstract][Full Text] [Related]
4. Deferoxamine-related ocular toxicity: incidence and outcome in a pediatric population.
Baath JS; Lam WC; Kirby M; Chun A
Retina; 2008 Jun; 28(6):894-9. PubMed ID: 18536609
[TBL] [Abstract][Full Text] [Related]
5. EOG as a monitor of desferrioxamine retinal toxicity.
Hidajat RR; McLay JL; Goode DH; Spearing RL
Doc Ophthalmol; 2004 Nov; 109(3):273-8. PubMed ID: 15957612
[TBL] [Abstract][Full Text] [Related]
6. Abnormal fundus autofluorescence results of patients in long-term treatment with deferoxamine.
Viola F; Barteselli G; Dell'arti L; Vezzola D; Villani E; Mapelli C; Zanaboni L; Cappellini MD; Ratiglia R
Ophthalmology; 2012 Aug; 119(8):1693-700. PubMed ID: 22480740
[TBL] [Abstract][Full Text] [Related]
7. Desferrioxamine related maculopathy: a case report.
Arora A; Wren S; Gregory Evans K
Am J Hematol; 2004 Aug; 76(4):386-8. PubMed ID: 15282675
[TBL] [Abstract][Full Text] [Related]
8. The utility of multifocal electroretinography in monitoring drug toxicity: deferoxamine retinopathy.
Kertes PJ; Lee TK; Coupland SG
Can J Ophthalmol; 2004 Oct; 39(6):656-61. PubMed ID: 15559652
[No Abstract] [Full Text] [Related]
9. Multimodal imaging in a case of deferoxamine-induced maculopathy.
Gelman R; Kiss S; Tsang SH
Retin Cases Brief Rep; 2014; 8(4):306-9. PubMed ID: 25372534
[TBL] [Abstract][Full Text] [Related]
10. Bilateral vitelliform maculopathy and deferoxamine toxicity.
Gonzales CR; Lin AP; Engstrom RE; Kreiger AE
Retina; 2004 Jun; 24(3):464-7. PubMed ID: 15187676
[No Abstract] [Full Text] [Related]
11. HIF2α activation and mitochondrial deficit due to iron chelation cause retinal atrophy.
Kong Y; Liu PK; Li Y; Nolan ND; Quinn PMJ; Hsu CW; Jenny LA; Zhao J; Cui X; Chang YJ; Wert KJ; Sparrow JR; Wang NK; Tsang SH
EMBO Mol Med; 2023 Feb; 15(2):e16525. PubMed ID: 36645044
[TBL] [Abstract][Full Text] [Related]
12. Recent developments in iron chelation therapy.
Cario H; Janka-Schaub G; Janssen G; Jarisch A; Strauss G; Kohne E
Klin Padiatr; 2007; 219(3):158-65. PubMed ID: 17525910
[TBL] [Abstract][Full Text] [Related]
13. Results of long-term iron-chelating therapy.
Gabutti V; Piga A
Acta Haematol; 1996; 95(1):26-36. PubMed ID: 8604584
[TBL] [Abstract][Full Text] [Related]
14. Deferoxamine (Desferal)-induced toxic retinal pigmentary degeneration and presumed optic neuropathy.
Lakhanpal V; Schocket SS; Jiji R
Ophthalmology; 1984 May; 91(5):443-51. PubMed ID: 6739047
[TBL] [Abstract][Full Text] [Related]
15. Deferoxamine-related bilateral maculopathy with optical coherence tomography findings.
Bayraktar Bilen N; Polat Gültekin B; Dagdas S; Kalayci D
Photodiagnosis Photodyn Ther; 2024 Feb; 45():103961. PubMed ID: 38163453
[TBL] [Abstract][Full Text] [Related]
16. [Ocular toxicity of deferoxamine: description and analysis of three observations].
Szwarcberg J; Mack G; Flament J
J Fr Ophtalmol; 2002 Jun; 25(6):609-14. PubMed ID: 12223949
[TBL] [Abstract][Full Text] [Related]
17. Deferoxamine retinopathy: spectral domain-optical coherence tomography findings.
Wu CH; Yang CP; Lai CC; Wu WC; Chen YH
BMC Ophthalmol; 2014 Jul; 14():88. PubMed ID: 24989140
[TBL] [Abstract][Full Text] [Related]
18. Retinal abnormalities in β-thalassemia major.
Bhoiwala DL; Dunaief JL
Surv Ophthalmol; 2016; 61(1):33-50. PubMed ID: 26325202
[TBL] [Abstract][Full Text] [Related]
19. Iron chelation by deferoxamine in sickle cell patients with severe transfusion-induced hemosiderosis: a randomized, double-blind study of the dose-response relationship.
Silliman CC; Peterson VM; Mellman DL; Dixon DJ; Hambidge KM; Lane PA
J Lab Clin Med; 1993 Jul; 122(1):48-54. PubMed ID: 8320490
[TBL] [Abstract][Full Text] [Related]
20. Pattern dystrophies in patients treated with deferoxamine: report of two cases and review of the literature.
Georgakopoulos CD; Tsapardoni F; Kostopoulou EV; Makri OE
BMC Ophthalmol; 2018 Sep; 18(1):246. PubMed ID: 30208862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
